Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Tumor Boards
Colleague Insights
Living Resources
Conferences
Nursing Perspectives
Video Expert Opinion
Sign in
Join now
story of the week
Published in Metastatic Breast Cancer and
1 other channel

Journal Scan / Research · April 30, 2019

Palbociclib Plus Letrozole Improves Outcomes in HR+, HER2– Advanced Breast Cancer

Clinical Breast Cancer

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Reshma Mahtani DO

Reshma Mahtani DO

Lillie Shockney RN, BS, MAS, HON-ONN-CG

Clinical Breast Cancer
Treatment Patterns and Outcomes Associated With Palbociclib Plus Letrozole for Postmenopausal Women With HR+/HER2– Advanced Breast Cancer Enrolled in an Expanded Access Program
Clin. Breast Cancer 2019 Apr 18;[EPub Ahead of Print], A Brufsky, D Mitra, KL Davis, SP Nagar, L McRoy, MJ Cotter, V Stearns

Further Reading

Most Read This Week

Recently Updated